EP1144448A3 - Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor - Google Patents

Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor

Info

Publication number: EP1144448A3
Authority: EP; European Patent Office
Prior art keywords: tiam2; metastasis; cell lymphoma; nucleotide exchange; exchange factor
Prior art date: 1999-01-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00902369A

Other languages

German (de)

French (fr)

Other versions

EP1144448A2 (en

Inventor

David Duhl

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis Vaccines and Diagnostics Inc

Original Assignee

Chiron Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-06

Filing date

2000-01-06

Publication date

2002-03-06

2000-01-06 Application filed by Chiron Corp filed Critical Chiron Corp

2001-10-17 Publication of EP1144448A2 publication Critical patent/EP1144448A2/en

2002-03-06 Publication of EP1144448A3 publication Critical patent/EP1144448A3/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Toxicology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)

EP00902369A 1999-01-06 2000-01-06 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor Withdrawn EP1144448A3 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US22727899A	1999-01-06	1999-01-06
US227278		1999-01-06
PCT/US2000/000459 WO2000040607A2 (en)	1999-01-06	2000-01-06	Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor

Publications (2)

Publication Number	Publication Date
EP1144448A2 EP1144448A2 (en)	2001-10-17
EP1144448A3 true EP1144448A3 (en)	2002-03-06

Family

ID=22852486

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00902369A Withdrawn EP1144448A3 (en)	1999-01-06	2000-01-06	Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor

Country Status (4)

Country	Link
EP (1)	EP1144448A3 (en)
JP (3)	JP4707235B2 (en)
AU (1)	AU2409700A (en)
WO (1)	WO2000040607A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002026817A2 (en) *	2000-09-25	2002-04-04	Millennium Pharmaceuticals, Inc.	33521, a human guanine nucleotide exchange family member and uses thereof
EP1752040A1 (en) *	2005-08-12	2007-02-14	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Isolation of the t-complex distorters and applications thereof
US8679760B2 (en) *	2011-05-03	2014-03-25	National Cheng Kung University	Biomarker and method for evaluating risk of proliferation, invasion, or metastasis of cancer
JP6675287B2 (en)	2016-08-23	2020-04-01	日機装株式会社	Fluid sterilizer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997046680A1 (en) *	1996-06-05	1997-12-11	Chiron Corporation	Dna encoding dp. 75 and a process for its use

2000
- 2000-01-06 WO PCT/US2000/000459 patent/WO2000040607A2/en active Application Filing
- 2000-01-06 JP JP2000592315A patent/JP4707235B2/en not_active Expired - Fee Related
- 2000-01-06 AU AU24097/00A patent/AU2409700A/en not_active Abandoned
- 2000-01-06 EP EP00902369A patent/EP1144448A3/en not_active Withdrawn
2010
- 2010-05-21 JP JP2010117840A patent/JP2010233574A/en not_active Withdrawn
2011
- 2011-02-01 JP JP2011020242A patent/JP2011083295A/en not_active Withdrawn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997046680A1 (en) *	1996-06-05	1997-12-11	Chiron Corporation	Dna encoding dp. 75 and a process for its use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHIU C.Y. ET AL.: "Cloning and characterization of T-cell lymphoma invasion and metastasis 2 (TIAM2), a novel guanine nucleotide exchange factor related to TIAM1.", GENOMICS, vol. 61, no. 1, 1 October 1999 (1999-10-01), pages 66-73, XP000864676 *
CHIU C.Y. ET AL.: "Erratum: Cloning and characterization of T-cell lymphoma invasion and metastasis 2 (TIAM2), a novel guanine nucleotide exchange factor related to TIAM1.", GENOMICS, vol. 63, no. 3, 2000, pages 439, XP000864677 *
HOSHINO M. ET AL.: "Identification of the stef Gene That Encodes a Novel Guanine Nucleotide Exchange Factor Specific for Rac1", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 25, 18 June 1999 (1999-06-18), pages 17837 - 17844, XP002141545 *
HOSHINO M.: "Mus musculus Stef mRNA for sif and Tiam1-like exchange factor, complete cds", EMBL DATABASE ENTRY AB022915; ACCESSION NO. AB022915, 30 June 1999 (1999-06-30), XP002141546 *
LEEUWEN F.N. ET AL.: "The Guanine Nucleotide Exchange Factor Tiam1 Affects Neuronal Morphology; Opposing Roles for the Small GTPases Rac and Rho", JOURNAL OF CELL BIOLOGY, vol. 139, no. 3, 3 November 1997 (1997-11-03), pages 797 - 807, XP002141547 *

Also Published As

Publication number	Publication date
JP2010233574A (en)	2010-10-21
AU2409700A (en)	2000-07-24
WO2000040607A2 (en)	2000-07-13
JP2011083295A (en)	2011-04-28
JP4707235B2 (en)	2011-06-22
JP2002538774A (en)	2002-11-19
WO2000040607A3 (en)	2001-11-01
EP1144448A2 (en)	2001-10-17

Publication	Publication Date	Title
AU4198299A (en)	1999-12-06	Compounds and uses thereof
AU1945101A (en)	2001-06-18	Heat-relaxable substrates and arrays
AU6513299A (en)	2000-05-01	3x adder
AU7073800A (en)	2001-03-19	Novel plexins and uses thereof
AU2088801A (en)	2001-06-18	Metastasis genes and uses thereof
AU3072500A (en)	2000-08-07	Rhamnosyl-transferase gene and uses thereof
AUPP433398A0 (en)	1998-07-16	Compounds and processes
AU8979698A (en)	1999-03-08	Solutions containing azasteroids
AU5697699A (en)	2000-03-27	Oligonucleotide protecting groups
AU8682998A (en)	1999-06-07	Improvement in chemical analyses
AU6417799A (en)	2000-05-01	Matrix-remodeling genes
EP1144448A3 (en)	2002-03-06	Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
AU2295201A (en)	2001-07-16	Spore-like cells and uses thereof
AUPP617598A0 (en)	1998-10-22	Genetic sequence and uses therefor
AU1894601A (en)	2001-07-03	Novel gene and use thereof
AU6008000A (en)	2001-02-13	Chemical compounds-ii
AU5979300A (en)	2001-01-22	Angiopoietin-6 and uses thereof
AU5429999A (en)	2000-02-28	Plant resistance gene
AU5052999A (en)	2000-02-21	Human ccr-2 gene polymorphisms
WO2000018211A9 (en)	2009-11-19	A novel cochlear gene coch5b2 and uses therefor
AU1396100A (en)	2000-06-13	Oligonucleotide conjugation
AU4513599A (en)	2000-01-24	Nucleotide sequence
AUPP549898A0 (en)	1998-09-17	Genetic sequences and uses therefor
EP1127062A4 (en)	2005-04-06	Lymphoma associated molecules and uses therefor
AU6006000A (en)	2001-02-13	Chemical compounds-iii

Legal Events

Date	Code	Title	Description
2001-08-31	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2001-10-17	17P	Request for examination filed	Effective date: 20010713
2001-10-17	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2001-10-17	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2001-10-17	XX	Miscellaneous (additional remarks)	Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.
2002-01-18	PUAK	Availability of information related to the publication of the international search report	Free format text: ORIGINAL CODE: 0009015
2002-03-06	AK	Designated contracting states	Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-03-06	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2005-01-19	RIC1	Information provided on ipc code assigned before grant	Ipc: 7C 12N 15/63 B Ipc: 7C 07K 14/47 A Ipc: 7G 01N 33/53 B Ipc: 7C 07K 16/18 B Ipc: 7C 12N 15/11 B
2007-01-24	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
2013-09-06	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-10-09	18D	Application deemed to be withdrawn	Effective date: 20130416